関連文献

The Possibility of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker of Renal Hypoxia in Spontaneously Diabetic Torii Fatty Rats.

Kidney Blood Press Res. 2019PubMed

Utility of urinary liver-type fatty acid-binding protein as a predictor of renal dysfunction in Japanese patients with HIV receiving tenofovir disoproxil fumarate with low urinary β2 microglobulin levels: a retrospective observational study.

J Pharm Health Care Sci. 2019PubMed

Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice.

Hypertens Res. 2019PubMed

Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study.

Diabetol Int. 2018PubMed

Urinary Level of Liver-Type Fatty Acid Binding Protein Reflects the Degree of Tubulointerstitial Damage in Polycystic Kidney Disease.

Kidney Blood Press Res. 2018PubMed

Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study.

Int J STD AIDS. 2018PubMed

Urinary L-FABP level in children with nephrotic syndrome and tubular dysfunction.

Pediatr Int. 2018PubMed

Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucoselowering-independent manner.

BMJ Open Diabetes Res Care. 2017PubMed

Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography.

QJM. 2018PubMed

Role of bardoxolone methyl, a nuclear factor erythroid 2-related factor 2 activator, in aldosterone- and salt-induced renal injury.

Hypertens Res. 2017PubMed